The importance of collaboration: an interview with Chas Bountra
We spoke to Professor Chas Bountra, Chief Scientist at the Structural Genomics Consortium (Oxford, UK), to find out more about his work in drug discovery for neurodegenerative disease and how the field can be advanced.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>